Skip Navigation


Carcinogenesis Advance Access originally published online on April 19, 2006
Carcinogenesis 2006 27(9):1883-1893; doi:10.1093/carcin/bgl041
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/9/1883    most recent
bgl041v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bao, B.-Y.
Right arrow Articles by Lee, Y.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bao, B.-Y.
Right arrow Articles by Lee, Y.-F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

1{alpha}, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis

Bo-Ying Bao1,2, Jorge Yao3 and Yi-Fen Lee1,*

1 Department of Urology, University of Rochester Rochester, NY 14642, USA
2 Department of Chemical Engineering, University of Rochester Rochester, NY 14642, USA
3 Department of Pathology, University of Rochester Rochester, NY 14642, USA

*To whom correspondence and requests for reprints should be addressed: Department of Urology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 656, Rochester, NY 14642, USA. Tel: +1 585 275 9702; Fax: +1 585 756 4133; Email: yifen_lee{at}urmc.rochester.edu

Angiogenesis is an essential step in initial tumor development and metastasis. Consequently, compounds that inhibit angiogenesis would be useful in treating cancer. A variety of antitumor effects mediated by 1{alpha}, 25-dihydroxyvitamin D3 (1,25-VD) have been reported, one of which is anti-angiogenesis; however, detailed mechanisms remain unclear. We have demonstrated that 1,25-VD inhibits prostate cancer (PCa) cell-induced human umbilical vein endothelial cell migration and tube formation, two critical steps involved in the angiogenesis. An angiogenesis factor, interleukin-8 (IL-8), secreted from PCa cell was suppressed by 1,25-VD at both mRNA and protein levels. Mechanistic dissection found that 1,25-VD inhibits NF-{kappa}B signal, one of the most important IL-8 upstream regulators. The 1,25-VD-mediated NF-{kappa}B signal reduction was shown to result from the blocking of nuclear translocation of p65, a subunit of the NF-{kappa}B complex, and was followed by attenuation of the NF-{kappa}B complex binding to DNA. The role of IL-8 in PCa progression was further examined by PCa tissue microarray analyses. We found that IL-8 expression was elevated during PCa progression, which suggests that IL-8 may play a role in tumor progression mediated through its stimulation on angiogenesis. These findings indicate that 1,25-VD could prevent PCa progression by interrupting IL-8 signaling, which is required in tumor angiogenesis, and thus applying vitamin D in PCa treatment may be beneficial for controlling disease progression.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
N.-C. Liu, W.-J. Lin, E. Kim, L. L. Collins, H.-Y. Lin, I-C. Yu, J. D. Sparks, L.-M. Chen, Y.-F. Lee, and C. Chang
Loss of TR4 Orphan Nuclear Receptor Reduces Phosphoenolpyruvate Carboxykinase Mediated Gluconeogenesis
Diabetes, December 1, 2007; 56(12): 2901 - 2909.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Nonn, D. Duong, and D. M. Peehl
Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells
Carcinogenesis, June 1, 2007; 28(6): 1188 - 1196.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.